MRC1 and cancer: LS presents with a highly heterogeneous phenotype, as shown by substantial differences in cancer penetrance (lifetime cancer risk) and expressivity (malignancies in specific organs) among individuals harboring genetic variants in a specific altered MMR gene [3].